Keyphrases
Age Groups
14%
All Ages
14%
Cape Town
100%
Cervical Cancer
14%
Cervical Cancer Screening
14%
Cervical Disease
14%
Cervical Intraepithelial Neoplasia
85%
Colposcopy
14%
Disease Status
14%
DNA Hybridization
14%
Genotype
14%
High Risk
14%
High-risk Human Papillomavirus (HR-HPV)
57%
HIV Status
42%
HIV-negative
100%
HIV-positive
100%
HPV16
28%
Human Papillomavirus Genotypes
100%
Human Papillomavirus Prevalence
28%
Human Papillomavirus Types
42%
Human Papillomavirus Vaccine
14%
Papillomavirus Infections
14%
Positive Samples
14%
Screening Strategy
14%
South Africa
100%
Sub-Saharan Africa
14%
Type Distribution
14%
Young Women
28%
Medicine and Dentistry
Biopsy
4%
Cervical Cancer
4%
Cervical Cancer Screening
4%
Cervical Intraepithelial Neoplasia
19%
Colposcopy
4%
Disease
9%
DNA Hybrid
4%
Genotype
4%
Human Immunodeficiency Virus
100%
Human Papillomavirus Type 16
4%
Human Papillomavirus Type 18
4%
Human Papillomavirus Type 35
4%
Human Papillomavirus Type 58
4%
Infection
4%
Papillomavirus Infection
4%
Population
4%
Prevalence
14%
Wart Virus
100%
Nursing and Health Professions
Biopsy
4%
Cancer Screening
4%
Colposcopy
4%
Disease
9%
DNA Hybrid
4%
Human Immunodeficiency Virus
100%
Human Papillomavirus DNA Test
4%
Infection
4%
Papillomavirus Infection
4%
Population
4%
Prevalence
14%
South Africa
100%
Uterine Cervix Cancer
9%
Uterine Cervix Carcinoma in Situ
19%
Vaccination Policy
4%
Biochemistry, Genetics and Molecular Biology
Cancer Screening
4%
Genotyping
9%
Human Immunodeficiency Virus
100%
Human Papillomavirus Type 16
4%
Human Papillomavirus Type 18
4%
Human Papillomavirus Type 35
4%
Human Papillomavirus Type 58
4%
Population
4%
Prevalence
14%
Wart Virus
100%
Immunology and Microbiology
Cancer Screening
4%
Genotype
4%
Human Immunodeficiency Virus
100%
Human Papillomavirus Type 16
4%
Human Papillomavirus Type 18
4%
Human Papillomavirus Type 35
4%
Human Papillomavirus Type 58
4%
Population
4%
Prevalence
14%
Vaccination Policy
4%
Wart Virus
100%